“Measurable Residual Disease Monitoring by Multiparameter Flow Cytometry and Relapse Prediction in Adult Acute Myeloid Leukemia”, ALR, vol. 5, no. 1, pp. 1–6, Aug. 2024, doi: 10.5281/zenodo.22227540.